Drugs

News and Updates about the regulations in Drugs and Pharma

NIIMS Medical College Celebrates Successful Conclusion of GENOME 2024: A Three-Day Multicultural Event

The Noida International Institute of Medical Sciences (NIIMS) recently announced the triumphant wrap-up of GENOME 2024, a vibrant three-day multicultural festivity crafted by fourth-year students from the 2020 batch. This event aimed to highlight the artistic flair, talents, and transition

NIIMS Medical College Celebrates Successful Conclusion of GENOME 2024: A Three-Day Multicultural Event Read More »

Quest Diagnostics Launches Personal Health Coaching on questhealth.com for Enhanced Wellness Management

Individualized health coaching options are now available for purchase on questhealth.com. Offered through Pack Health, a subsidiary of Quest Diagnostics known for its evidence-based patient interaction services, the platform pairs users with certified health coaches. These professionals offer focused support,

Quest Diagnostics Launches Personal Health Coaching on questhealth.com for Enhanced Wellness Management Read More »

GE HealthCare Seeks FDA 510(k) for AI-Enhanced CleaRecon DL to Boost Interventional Suite Imaging

GE HealthCare, renowned for its innovations in medical technology, pharmaceutical diagnostics, and digital solutions, has submitted a 510(k) application to the U.S. Food and Drug Administration (FDA) for approval of CleaRecon DL. This cutting-edge deep learning technology aims to uplift

GE HealthCare Seeks FDA 510(k) for AI-Enhanced CleaRecon DL to Boost Interventional Suite Imaging Read More »

Orphan Drug Status Awarded to RESTEM’s ULSC Initiative by the FDA for Polymyositis and Dermatomyositis Treatment

RESTEM, a biotechnological firm at the clinical-stage, dedicated to crafting innovative cell therapies that are readily available and aim to regulate the immune response, has disclosed that the United States Food and Drug Administration (FDA) has bestowed Orphan Drug Designation

Orphan Drug Status Awarded to RESTEM’s ULSC Initiative by the FDA for Polymyositis and Dermatomyositis Treatment Read More »

Dentalkart Secures Rs. 85 Crore Funding from International Investors for Growth and Subsidiary Expansion

Dentalkart, the pioneering and largest online hub for dental products in India, has garnered Rs. 85 crore in a recent financing round. This investment, headed by international investors Malabar Investment and Whiteoak, underscores the company’s dedication to transforming the dental

Dentalkart Secures Rs. 85 Crore Funding from International Investors for Growth and Subsidiary Expansion Read More »